Synthetic Biology: Recent Trends & Research

Startup Scout 13 Dec 2022

Biomemory is making DNA hard drives cheap and sustainable

The world is running out of ways to store the mountains of data we produce. Biomemory is creating DNA-based hard drives that could store this information cheaply, sustainably and for centuries. Society has advanced very far in technologies to store critical data, moving from punched cards and floppy disks in the 20th century to hard […]

December 13, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 28 Nov 2022

Biomemory raises €5M to advance DNA digital data storage solution

Biomemory, a start-up focused on DNA data synthesis and storage, has closed a €5 million ($5.2 million) seed investment for the development of its technology. The seed funding round was led by eureKARE and the French Tech Seed Fund, managed on behalf of the French State by Bpifrance within the scope of France 2030, with […]

November 28, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 17 Nov 2022

Startup Cradle raises $5.4M to design protein machines and cell factories with AI

Cradle, a Dutch startup, has received €5.5 million ($5.4 million) in seed funding to further help scientists design and program proteins to produce a wide variety of everyday products including milk and meat. Cradle uses synthetic biology, adapting the genes of microorganisms such as bacteria and fungi, to create ‘cell factories’ that use programmable proteins […]

November 17, 2022 - 5 minutesmins - By Liza Laws

In Depth 17 Oct 2022

UK grants that can give biotech startups a vital jump-start

Grants are a vital lifeline that help biotech startups get off the ground, especially for underrepresented entrepreneurs. The Women in Synthetic Biology (WiSB) network recently gave detailed advice for helping U.K. biotech founders access this funding. Women are a big source of talent in the biotech space, both in academic life sciences and in founding […]

October 17, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 7 Sep 2022

Lesaffre acquires genome editing company Recombia Biosciences

Lesaffre has acquired Recombia Biosciences, a biotech company based in the San Francisco Bay Area founded in 2019 based on technology licensed from Stanford University. This acquisition is the culmination of a strategic partnership initiated in 2020 to leverage Recombia Biosciences’ genome-editing technologies and accelerate the development of yeasts for sustainable production of fermented ingredients. […]

September 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 31 Aug 2022

Anti-cancer drug created from reprogrammed yeast

Engineered yeast cells can synthetically produce the essential cancer medicine vinblastine, an international team of scientists showed in a new study published in Nature. In the summer and fall of 2019, some cancer patients experienced interruptions in their treatment. The reason was a shortage of the drugs vinblastine and vincristine, essential chemotherapeutic medicines for several […]

August 31, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 17 Aug 2022

Researchers invited to apply for DNA synthesized by Evonetix’s platform

An early access program for semiconductor synthesized DNA has been opened by UK-based gene synthetic biology company, Evonetix. Evonetix’s DNA synthesis capability brings together semiconductor chip design and proprietary, thermally controlled synthesis chemistry, integral to the company’s future gene synthesis platforms. Silicon chip The company’s proprietary process utilizes a silicon chip to control the synthesis […]

August 17, 2022 - 2 minutesmins - By Liza Laws

In Depth 11 Aug 2022

Biosecurity is synthetic biology’s most crucial ally

Synthetic biology has made it easier than ever to engineer organisms to serve our needs. But as the technology becomes widespread, concerns about its potential misuse arise. How can we ensure biosecurity without hindering the advance of synthetic biology? Biosecurity consists of the prevention of and response to the release of potentially harmful organisms. Now […]

August 11, 2022 - 6 minutesmins - By Kostas Vavitsas

News and Trends 19 Jul 2022

eureKARE launches synthetic biology studio network

eureKARE, a company focused on financing and building next generation biotech companies in the fields of synthetic biology, has launched its first synthetic biology studio in Belgium. In conjunction with this, eureKARE has appointed Georges Rawadi as chief of biotech studio development. eureKARE said its thematic synthetic biology studio model is a novel, flexible approach […]

July 19, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 23 Jun 2022

Antheia gets funding to build biomanufacturing plant

Antheia, a U.S. synthetic biology company enabling next-generation plant-inspired medicines, has announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank. The company also unveiled plans to construct a new pilot scale biomanufacturing facility. The financing will support Antheia’s expansion with a 14,700 square-foot pilot plant located next to Antheia’s […]

June 23, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Feb 2022

Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A

The Viennese biotech startup Ribbon Biolabs has raised an €18M Series A round to reduce the costs of synthesizing long DNA molecules, which could accelerate research into synthetic biology and the storage of data as DNA. Supported by lead investor Hadean Ventures, Ribbon Biolabs’ fundraising round is part and parcel of a continuing investor interest […]

February 1, 2022 - 3 minutesmins - By Dan Samorodnitsky

Best in Biotech 14 Jul 2021

5 Easy DIY Biology Experiments You Can Do at Home

Here are five easy DIY biology experiments to have fun at home without the need for expensive laboratory equipment. Biology is fascinating, but not all of us have access to state-of-the-art laboratory equipment to do biology experiments. However, it is possible to do some simple experiments at home with the right materials. These DIY biology […]

July 14, 2021 - 6 minutesmins - By Clara Rodríguez Fernández

Resources

Categories

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Synthetic biology

Biomemory is making DNA hard drives cheap and sustainable

Biomemory raises €5M to advance DNA digital data storage solution

Startup Cradle raises $5.4M to design protein machines and cell factories with AI

UK grants that can give biotech startups a vital jump-start

Lesaffre acquires genome editing company Recombia Biosciences

Anti-cancer drug created from reprogrammed yeast

Researchers invited to apply for DNA synthesized by Evonetix’s platform

Biosecurity is synthetic biology’s most crucial ally

eureKARE launches synthetic biology studio network

Antheia gets funding to build biomanufacturing plant

Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A

5 Easy DIY Biology Experiments You Can Do at Home

Subscribe to our newsletter to get the latest biotech news!

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 biotech companies to watch in 2025

Biotech in 2024: A retrospective

Grab your free report on 3D organoids and explore their future potential

Five biosimilar companies you should know about

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!